Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRASP shoulder pain trial
ISRCTN16539266Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of methylprednisolone and triamcinolone acetonide in Rotator cuff deficiency (RCD) (4 arms), sponsored by University of Oxford. Primary endpoints: Shoulder pain and function and Questionnaire response rate. Started Feb 2017; status: completed.
02
Drugs
methylprednisolonetriamcinolone acetonide
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ISRCTN16539266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16539266.